Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. 119-61-9
2. Diphenylmethanone
3. Diphenyl Ketone
4. Benzoylbenzene
5. Methanone, Diphenyl-
6. Phenyl Ketone
7. Ketone, Diphenyl
8. Alpha-oxoditane
9. Benzene, Benzoyl-
10. Alpha-oxodiphenylmethane
11. Diphenylketone
12. Diphenyl-methanone
13. Kayacure Bp
14. .alpha.-oxoditane
15. Adjutan 6016
16. Fema No. 2134
17. .alpha.-oxodiphenylmethane
18. Diphenyl-methanon
19. 1dzp
20. Nsc 8077
21. Mfcd00003076
22. Chembl90039
23. 701m4ttv9o
24. Dtxsid0021961
25. Chebi:41308
26. Nsc-8077
27. Ncgc00090787-05
28. Dsstox_cid_1961
29. Dsstox_rid_76429
30. Dsstox_gsid_21961
31. Diphenylmethanone (benzophenone)
32. Caswell No. 081g
33. Cas-119-61-9
34. Ccris 629
35. Hsdb 6809
36. Wln: Rvr
37. Einecs 204-337-6
38. Epa Pesticide Chemical Code 000315
39. Benzophenone (8ci)
40. Phenylketone
41. Unii-701m4ttv9o
42. Benzopheneone
43. Benzophenon
44. Benzophenone-
45. Benzoyl-benzene
46. A-oxoditane
47. Ai3-00754
48. Meta-benzophenone
49. Alpha -oxoditane
50. Fema 2134
51. Benzophenone Flakes
52. Di(phenyl)methanone
53. A-oxodiphenylmethane
54. Methanone, Diphenyl- (9ci)
55. Ph2co
56. Speedcure Bp
57. Darocur Bp
58. Diphenylmethanone, 9ci
59. Alpha -oxodiphenylmethane
60. Dimenhydrinate Impurity J
61. Benzophenone [mi]
62. Benzophenone [fcc]
63. Upcmld-dp071
64. Benzophenone [fhfi]
65. Benzophenone [hsdb]
66. Benzophenone [iarc]
67. Benzophenone [inci]
68. Ec 204-337-6
69. Bidd:pxr0008
70. Schembl17745
71. Mls001055400
72. Adk Stab 1413
73. Benzophenone [usp-rs]
74. Benzophenone [who-dd]
75. Bidd:er0022
76. Benzophenone (diphenyl-ketone)
77. Benzophenone (diphenylmethanone)
78. Upcmld-dp071:001
79. Bdbm22726
80. Benzophenone, Analytical Standard
81. Diphenhydramine Impurity E
82. Amy7704
83. Nsc8077
84. Hms2268a24
85. Zinc968233
86. Benzophenone [usp Impurity]
87. Benzophenone, >=99%, Fcc, Fg
88. Hy-y0546
89. Tox21_113465
90. Tox21_202425
91. Tox21_300058
92. Benzophenone, Reagentplus(r), 99%
93. S4438
94. Stl363250
95. Benzophenone, For Synthesis, 98.0%
96. Akos000119029
97. Tox21_113465_1
98. Benzophenone (diphenyl-ketone)
99. Db01878
100. Benzophenone 100 Microg/ml In Methanol
101. Benzophenone, Purum, >=99.0% (gc)
102. Benzophenone, Reagentplus(r), >=99%
103. Ncgc00090787-01
104. Ncgc00090787-03
105. Ncgc00090787-04
106. Ncgc00090787-06
107. Ncgc00090787-07
108. Ncgc00090787-08
109. Ncgc00254183-01
110. Ncgc00259974-01
111. Bp-21212
112. Smr000112143
113. Phenytoin Impurity A [ep Impurity]
114. Benzophenone, Saj First Grade, >=99.0%
115. Db-061602
116. B0083
117. Cs-0015323
118. Ft-0622720
119. Ft-0693251
120. Benzophenone, Purified By Sublimation, >=99%
121. Benzophenone, Vetec(tm) Reagent Grade, 98%
122. C06354
123. D72506
124. Dimenhydrinate Impurity J [ep Impurity]
125. Phenytoin Sodium Impurity A [ep Impurity]
126. Q409482
127. Melting Point Standard 47-49c, Analytical Standard
128. Q-200691
129. Phenytoin Impurity Benzophenone [usp Impurity]
130. F0001-0309
131. Z1245792986
132. Benzophenone, European Pharmacopoeia (ep) Reference Standard
133. Diphenhydramine Hydrochloride Impurity E [ep Impurity]
134. Mettler-toledo Calibration Substance Me 18870, Benzophenone
135. Phenytoin Sodium Impurity Benzophenone [usp Impurity]
136. Benzophenone, United States Pharmacopeia (usp) Reference Standard
137. Hydrocodone Hydrogen Tartrate 2.5-hydrate Impurity H [ep Impurity]
138. Benzophenone, Pharmaceutical Secondary Standard; Certified Reference Material
139. Mettler-toledo Calibration Substance Me 18870, Benzophenone, For The Calibration Of The Thermosystem 900, Traceable To Primary Standards (lgc)
| Molecular Weight | 182.22 g/mol |
|---|---|
| Molecular Formula | C13H10O |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 182.073164938 g/mol |
| Monoisotopic Mass | 182.073164938 g/mol |
| Topological Polar Surface Area | 17.1 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 165 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Photosensitizing Agents
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)
The percutaneous absorption of benzophenone was determined in vivo in monkeys. Absorption through occluded skin was approximately 70% of the applied dose in 24 hr. Under unoccluded conditions skin penetration was reduced to 44%, presumably because of evaporation from the site of application.
European Commission/European Chemical Substances Information System; IUCLID Dataset, Benzophenone (CAS No. 119-61-9) (2000). Available from, as of March 18, 2015: https://esis.jrc.ec.europa.eu/
/The authors/ gave /benzophenone/ orally ... (100 or 400 mg/kg) ... once per day for 3 days, to ovariectomized Sprague-Dawley (SD) rats, and all rats were killed 24 h after being given the last dose. ... At 24 hr after the last dose, the mean serum concentrations of benzophenone, benzhydrol and p-hydroxybenzophenone in the high-dosed rats were 10.4+/-1.0, 1.5+/-0.3, and 0.7+/-0.2 (mean +/- SE) umol/L, respectively, whereas in the serum of low-dosed rats these compounds were not detected. When a single oral administration of benzophenone (100 or 400 mg/kg) was given to intact female rats, serum concentrations of benzophenone, benzhydrol and p-hydroxybenzophenone increased in a dose-dependent manner 6 hr later. ...
PMID:1245144 Nakagawa Y, Tayama K; Arch Toxicol 76 (12): 727-31 (2002)
... The percutaneous absorption of the fragrances benzyl acetate and five other benzyl derivatives (benzyl alcohol, benzyl benzoate, benzamide, benzoin and benzophenone) was determined in vivo in monkeys. Absorption through occluded skin was high for all cmpd (approx 70% of the applied dose in 24 hr) and no significant differences between the values for the different cmpd were observed. No correlations were seen between skin penetration of these cmpd and their octanol-water partition coefficients. Under unoccluded conditions skin penetration of the fragrances was reduced and there was great variability between cmpd, presumably because of variations in the rates of evaporation from the site of application.
PMID:2379896 Bronaugh RL et al; Food Chem Toxicol 28 (5): 369-73 (1990)
In male Sprague-Dawley rats that received benzophenone by gavage, 1% of the administered dose was detected as p-hydroxybenzophenone in enzymetreated urine samples, but not in unhydrolyzed urine (Stocklinski et al., 1979). No p-hydroxybenzophenone was detected in the feces.
DHHS/NTP; Toxicology and Carcinogenesis Studies of Benzophenone (CAS No. 119-61-9) Toxicity Report Series No. 61 NIH Pub No. 00-3943. Available from, as of March 18, 2015: https://ntp-server.niehs.nih.gov
The results from recent studies show that some benzophenones (BPs) and their hydroxylated metabolites can function as weak estrogens (E2) in the environment. However, little is known about the structure-activity relationship of these molecules. We have examined the effects of exposure to ten different BPs on the proliferation of estrogen receptor (ER)-positive breast cancer cells and on the transcriptional activity of E2-target genes. We analyzed two genes that are tightly linked with estrogen-mediated proliferation, the CXCL12 and amphiregulin genes and two classical estrogen-responsive genes, the pS2 and progesterone receptor. Significant differences in the BPs efficiency to induce cell proliferation and endogenous E2-target gene expressions were observed. Using ERE-, Sp1-, AP1- and C3-reporter genes that contain different ER-binding sites in their promoter, we also showed significant differences in the BPs efficiency in activation of the ER transactivation. Together, our analyzes showed that the most active molecule is 4-hydroxy-BP. Docking analysis of the interaction of BPs in the ligand-binding pocket of ERa suggests that the minimum structural requirement for the estrogenic activity of BPs is a hydroxyl (OH) group in the phenyl A-ring that allows interaction with Glu-353, Arg-394 or Phe-404, which enhances the stability between BPs and ERa. Our modeling also indicates a loss of interaction between the OH groups of the phenyl B-ring and His-524. In addition, the presence of some OH groups in the phenyl B-ring can create repulsion forces, which may constrain helix 12 in an unfavorable position, explaining the differential estrogenic effects of BPs. These results, together with our analysis of BPs for their potency in activation of cell proliferation and ER-mediated transcription, report an improved understanding of the mechanism and structure-activity relationship of BPs. /benzophenones/
Kerdivel G et al; PLoS One. 8(4):e60567 (2013)
Benzophenone's main metabolic pathway in the rabbit is by reduction to benzhydrol, which is excreted in urine conjugated with glucoronic acid. Small amount (1%) is converted to p-hydroxybenzophenone following oral administration to rats. No p-hydroxybenzohydrol was detected in urine or feces.
European Commission/European Chemical Substances Information System; IUCLID Dataset, Benzophenone (CAS No. 119-61-9) (2000). Available from, as of March 18, 2015: https://esis.jrc.ec.europa.eu/
Benzophenone is a known human metabolite of cinnarizine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shandong Focus Biotechnology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Film Formers & Plasticizers
Parenteral
Thickeners and Stabilizers
Fillers, Diluents & Binders
Emulsifying Agents
Taste Masking
Coating Systems & Additives
Chewable & Orodispersible Aids
Surfactant & Foaming Agents
Solubilizers
Direct Compression
Rheology Modifiers
Lubricants & Glidants
Co-Processed Excipients
API Stability Enhancers
Granulation
Soft Gelatin
Controlled & Modified Release
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
28
PharmaCompass offers a list of Benzophenone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzophenone manufacturer or Benzophenone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzophenone manufacturer or Benzophenone supplier.
PharmaCompass also assists you with knowing the Benzophenone API Price utilized in the formulation of products. Benzophenone API Price is not always fixed or binding as the Benzophenone Price is obtained through a variety of data sources. The Benzophenone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DIPHENHYDRAMINE IMPURITY E manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DIPHENHYDRAMINE IMPURITY E, including repackagers and relabelers. The FDA regulates DIPHENHYDRAMINE IMPURITY E manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DIPHENHYDRAMINE IMPURITY E API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DIPHENHYDRAMINE IMPURITY E manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DIPHENHYDRAMINE IMPURITY E supplier is an individual or a company that provides DIPHENHYDRAMINE IMPURITY E active pharmaceutical ingredient (API) or DIPHENHYDRAMINE IMPURITY E finished formulations upon request. The DIPHENHYDRAMINE IMPURITY E suppliers may include DIPHENHYDRAMINE IMPURITY E API manufacturers, exporters, distributors and traders.
click here to find a list of DIPHENHYDRAMINE IMPURITY E suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DIPHENHYDRAMINE IMPURITY E DMF (Drug Master File) is a document detailing the whole manufacturing process of DIPHENHYDRAMINE IMPURITY E active pharmaceutical ingredient (API) in detail. Different forms of DIPHENHYDRAMINE IMPURITY E DMFs exist exist since differing nations have different regulations, such as DIPHENHYDRAMINE IMPURITY E USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DIPHENHYDRAMINE IMPURITY E DMF submitted to regulatory agencies in the US is known as a USDMF. DIPHENHYDRAMINE IMPURITY E USDMF includes data on DIPHENHYDRAMINE IMPURITY E's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DIPHENHYDRAMINE IMPURITY E USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DIPHENHYDRAMINE IMPURITY E suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DIPHENHYDRAMINE IMPURITY E as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DIPHENHYDRAMINE IMPURITY E API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DIPHENHYDRAMINE IMPURITY E as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DIPHENHYDRAMINE IMPURITY E and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DIPHENHYDRAMINE IMPURITY E NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DIPHENHYDRAMINE IMPURITY E suppliers with NDC on PharmaCompass.
DIPHENHYDRAMINE IMPURITY E Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DIPHENHYDRAMINE IMPURITY E GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DIPHENHYDRAMINE IMPURITY E GMP manufacturer or DIPHENHYDRAMINE IMPURITY E GMP API supplier for your needs.
A DIPHENHYDRAMINE IMPURITY E CoA (Certificate of Analysis) is a formal document that attests to DIPHENHYDRAMINE IMPURITY E's compliance with DIPHENHYDRAMINE IMPURITY E specifications and serves as a tool for batch-level quality control.
DIPHENHYDRAMINE IMPURITY E CoA mostly includes findings from lab analyses of a specific batch. For each DIPHENHYDRAMINE IMPURITY E CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DIPHENHYDRAMINE IMPURITY E may be tested according to a variety of international standards, such as European Pharmacopoeia (DIPHENHYDRAMINE IMPURITY E EP), DIPHENHYDRAMINE IMPURITY E JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DIPHENHYDRAMINE IMPURITY E USP).
